Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas.

García-Inclán C, López F, Pérez-Escuredo J, Cuesta-Albalad MP, Vivanco B, Centeno I, Balbín M, Suárez C, Llorente JL, Hermsen MA.

Cell Oncol (Dordr). 2012 Dec;35(6):443-50. doi: 10.1007/s13402-012-0103-7. Epub 2012 Oct 11.

PMID:
23055340
2.

KRAS and BRAF mutations in sinonasal cancer.

López F, García Inclán C, Pérez-Escuredo J, Alvarez Marcos C, Scola B, Suárez C, Llorente JL, Hermsen MA.

Oral Oncol. 2012 Aug;48(8):692-7. doi: 10.1016/j.oraloncology.2012.02.018. Epub 2012 Mar 27.

PMID:
22459936
3.

Epidermal growth factor receptor expression and KRAS and BRAF mutations: study of 39 sinonasal intestinal-type adenocarcinomas.

Projetti F, Durand K, Chaunavel A, Léobon S, Lacorre S, Caire F, Bessède JP, Moreau JJ, Coulibaly B, Labrousse F.

Hum Pathol. 2013 Oct;44(10):2116-25. doi: 10.1016/j.humpath.2013.03.019. Epub 2013 Jun 20.

PMID:
23791006
4.

Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments.

Franchi A, Innocenti DR, Palomba A, Miligi L, Paiar F, Franzese C, Santucci M.

Pathol Oncol Res. 2014 Jul;20(3):571-9. doi: 10.1007/s12253-013-9730-1. Epub 2013 Dec 15.

PMID:
24338245
5.

EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.

Chiosea S, Shuai Y, Cieply K, Nikiforova MN, Dacic S.

Hum Pathol. 2010 Aug;41(8):1053-60. doi: 10.1016/j.humpath.2010.01.008. Epub 2010 Apr 8.

PMID:
20381121
6.

Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.

Salmaninejad A, Ghadami S, Dizaji MZ, Golchehre Z, Estiar MA, Zamani MR, Ebrahimzadeh-Vesal R, Nowroozi MR, Shakoori A.

Clin Lab. 2015;61(7):749-59.

PMID:
26299074
7.
8.

Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.

Seo AN, Yang JM, Kim H, Jheon S, Kim K, Lee CT, Jin Y, Yun S, Chung JH, Paik JH.

Br J Cancer. 2014 May 27;110(11):2688-99. doi: 10.1038/bjc.2014.218. Epub 2014 May 8.

9.

BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.

Pai RK, Jayachandran P, Koong AC, Chang DT, Kwok S, Ma L, Arber DA, Balise RR, Tubbs RR, Shadrach B, Pai RK.

Am J Surg Pathol. 2012 May;36(5):744-52. doi: 10.1097/PAS.0b013e31824430d7.

PMID:
22314188
10.

Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.

Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, Mañé B, Arcusa A, Agúndez JA, Blanca M, Carballo M.

BMC Cancer. 2011 Sep 24;11:406. doi: 10.1186/1471-2407-11-406.

11.

KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.

Pang NK, Nga ME, Chin SY, Ismail TM, Lim GL, Soong R, Salto-Tellez M.

Cytopathology. 2011 Dec;22(6):358-64. doi: 10.1111/j.1365-2303.2010.00812.x. Epub 2010 Oct 4.

PMID:
21029218
12.

KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.

Italiano A, Hostein I, Soubeyran I, Fabas T, Benchimol D, Evrard S, Gugenheim J, Becouarn Y, Brunet R, Fonck M, François E, Saint-Paul MC, Pedeutour F.

Ann Surg Oncol. 2010 May;17(5):1429-34. doi: 10.1245/s10434-009-0864-z. Epub 2010 Jan 5.

PMID:
20049644
13.

Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan.

Chang YT, Chang MC, Huang KW, Tung CC, Hsu C, Wong JM.

J Gastroenterol Hepatol. 2014 May;29(5):1119-25. doi: 10.1111/jgh.12505.

PMID:
24372748
14.

Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.

Grob TJ, Heilenkötter U, Geist S, Paluchowski P, Wilke C, Jaenicke F, Quaas A, Wilczak W, Choschzick M, Sauter G, Lebeau A.

Breast Cancer Res Treat. 2012 Jul;134(2):561-7. doi: 10.1007/s10549-012-2092-7. Epub 2012 May 19.

PMID:
22610646
15.

[Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].

Ling Y, Ying JM, Qiu T, Shan L, Guo L, Lü N.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):590-4. doi: 10.3760/cma.j.issn.0529-5807.2012.09.004. Chinese.

PMID:
23157825
16.

Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.

Wen YS, Cai L, Zhang XW, Zhu JF, Zhang ZC, Shao JY, Zhang LJ.

Medicine (Baltimore). 2014 Dec;93(29):e296. doi: 10.1097/MD.0000000000000296.

17.

Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients.

Carneiro JG, Couto PG, Bastos-Rodrigues L, Bicalho MA, Vidigal PV, Vilhena A, Amaral NF, Bale AE, Friedman E, De Marco L.

Genet Res (Camb). 2014;96:e002. doi: 10.1017/S0016672314000032. Epub 2014 Mar 5.

PMID:
24594201
18.

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.

Guedes JG, Veiga I, Rocha P, Pinto P, Pinto C, Pinheiro M, Peixoto A, Fragoso M, Raimundo A, Ferreira P, Machado M, Sousa N, Lopes P, Araújo A, Macedo J, Alves F, Coutinho C, Henrique R, Santos LL, Teixeira MR.

BMC Cancer. 2013 Apr 1;13:169. doi: 10.1186/1471-2407-13-169.

19.

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.

Schmid K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M.

Clin Cancer Res. 2009 Jul 15;15(14):4554-60. doi: 10.1158/1078-0432.CCR-09-0089. Epub 2009 Jul 7.

20.

A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.

Kawazoe A, Shitara K, Fukuoka S, Kuboki Y, Bando H, Okamoto W, Kojima T, Fuse N, Yamanaka T, Doi T, Ohtsu A, Yoshino T.

BMC Cancer. 2015 Apr 11;15:258. doi: 10.1186/s12885-015-1276-z.

Supplemental Content

Support Center